News & Updates
Filter by Specialty:
BNT162b2 booster protects against COVID-19 infection, hospitalization in adolescents
In a national cohort study in Singapore, a booster dose of BNT162b2 maintained individual protection against severe COVID-19 disease among adolescents aged 12–17 years.
BNT162b2 booster protects against COVID-19 infection, hospitalization in adolescents
13 Jun 2023
Post-treatment HBsAg loss greater with TDF vs entecavir
In patients with chronic hepatitis B (CHB) without cirrhosis, the rates of hepatitis B surface antigen (HBsAg) loss appear to be higher after discontinuation of tenofovir disoproxil fumarate (TDF) than of entecavir, and this is particularly true for patients who have not experienced relapse after treatment discontinuation, according to a study.
Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023
Vaccination uptake among kids in SG: Flu shots lag behind pneumococcal vax
Not enough children in Singapore are getting vaccinated against influenza, whereas the number of those who are receiving pneumococcal shots has steadily increased over time.
Vaccination uptake among kids in SG: Flu shots lag behind pneumococcal vax
08 Jun 2023
T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
A retrospective observational study of nearly 28,000 patients with type 2 diabetes mellitus (T2DM) in Hong Kong finds that use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is independently associated with lower rates of ICU admission and all-cause mortality across various disease categories.